Prostate Cancer Diagnostics Global Market Report 2025

Global Prostate Cancer Diagnostics Market Report 2024

Prostate Cancer Diagnostics Global Market Report 2025 – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma), By Peer Groups (Adult, Pediatric, Geriatrics), By End User (Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Prostate Cancer Diagnostics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Prostate Cancer Diagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Prostate Cancer Diagnostics Global Market Report 2025

Proud Members Of

Prostate Cancer Diagnostics Market Definition

Prostate cancer diagnostics refers to the process of determining and verifying the presence of prostate cancer using diagnostic testing and medical evaluations to evaluate the status and severity of the illness and direct treatment choices. It is commonly used to treat prostatic adenocarcinoma, transitional cell carcinomas, and neuroendocrine tumors.

The main products of prostate cancer diagnostics are instruments, reagents and consumables, accessories. Accessories refer to items in the kit that are not typically necessary but can be used with or added to something else to make it more effective, a prostate-specific antigen (PSA) test kit, biopsy needle, and ultrasound gel are used in the diagnosis of prostate cancer. The various test types include preliminary tests and confirmatory tests that diagnose various prostate cancers such as squamous cell cancer, small cell carcinoma, transitional cell cancer, prostatic adenocarcinoma, ductal adenocarcinoma, small cell prostate cancer, acinar adenocarcinoma. These are used by various peer groups such as adult, pediatric, and geriatrics and also performed by various end users such as hospitals, independent diagnostic laboratories, cancer research institutes, others

Prostate Cancer Diagnostics Market Segmentation

The prostate cancer diagnostics market covered in this report is segmented –

1) By Products: Instruments, Reagents And Consumables, Accessories

2) By Test Type: Preliminary Tests, Confirmatory Tests

3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma

4) By Peer Groups: Adult, Pediatric, Geriatrics

5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Biopsy Instruments, Imaging Devices, Digital Rectal Examination Tools

2) By Reagents And Consumables: Diagnostic Assay Kits, Staining Reagents, Sample Collection Materials

3) By Accessories: Biopsy Guides, Specimen Handling Accessories, Calibration And Maintenance Tools

Prostate Cancer Diagnostics Market Size and growth rate 2025 to 2029: Graph

Prostate Cancer Diagnostics Market Size 2025 And Growth Rate

The prostate cancer diagnostics market size has grown rapidly in recent years. It will grow from $4.43 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to the increasing aging population, advancements in medical imaging, rising awareness and screening programs, public health initiatives, and improved biopsy techniques

Prostate Cancer Diagnostics Market Growth Forecast

The prostate cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $8.17 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the integration of artificial intelligence (AI), growth of telemedicine in cancer screening, advancements in genomic profiling, patient-centric approaches, and multiparametric MRI for diagnosis. Major trends in the forecast period include liquid biopsy technologies, technological advances in biomarker detection, clinical research and development, digital pathology integration, emergence of multiplex biomarker assays.

Book your 30 minutes free consultation with our research experts

Prostate Cancer Diagnostics Market Driver: Global Surge In Prostate Cancer Cases Drives Expansion Of Prostate Cancer Diagnostics Market

The increasing prevalence of prostate cancer is expected to propel the growth of the prostate cancer diagnostics market going forward. Prostate cancer is a condition in which cancer arises in the prostate gland, a component of the male and female reproductive systems. Prostate cancer diagnostics helps patients to diagnose the disease early with various tests, including prostate-specific antigen (PSA) testing and sophisticated imaging techniques. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based non-profit organization dedicated to eliminating cancer, approximately 288,300 new cases of prostate cancer and 34,700 deaths attributed to prostate cancer in 2023. Therefore, the increasing prevalence of prostate cancer is expected to propel the growth of the prostate cancer diagnostics market.

Prostate Cancer Diagnostics Market Driver: A Surge In Spending Accelerates Prostate Cancer Diagnosis Market

The increase in healthcare spending is driving the growth of the prostate cancer diagnosis market. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending allocates and uses resources for prostate cancer diagnosis to facilitate early detection, accurate staging, and timely intervention, aiming to improve patient outcomes, survival rates, and the overall quality of care for individuals affected by prostate cancer. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, an increase in healthcare spending is driving the growth of the prostate cancer diagnosis market going forward.

Global Prostate Cancer Diagnostics Market Major Players

Major companies operating in the prostate cancer diagnostics market include F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc, Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc, NeoGenomics Laboratories Inc., Guardant Health Inc, GRAIL Inc, Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd, Exosome Diagnostics Inc., Dana-Farber Cancer Institute, Cellanyx Diagnostics Inc., A3P Biomedical AB

Global Prostate Cancer Diagnostics Market Trend: Innovative Technological Advancements Propel Prostate Cancer Diagnostics Market

Technological innovations are a key trend gaining popularity in the prostate cancer diagnostics market. Major companies operating in prostate cancer diagnostics are introducing innovative AI-powered prostate cancer diagnosis tools to sustain their position in the market. For instance, in March 2023, Qritive, a Singapore-based company that develops diagnostic tools, launched QAi Prostate, an advanced AI-powered prostate cancer diagnosis tool for pathologists. These tools include advanced machine learning algorithms that identify the prostatic adenocarcinoma region and analyze whole slide images of prostate core needle biopsies. This tool helps pathologists to perform accurate diagnoses quickly and reduces the time taken for the treatment.

Global Prostate Cancer Diagnostics Market Trend: Lantheus Holdings Inc. And Novartis AG Forge Strategic Partnership To Propel Precision Medicine In Prostate Cancer Diagnostics

Major companies operating in the prostate cancer diagnostics market are adopting a strategic partnership approach to advance cancer precision medicine by enabling partners to use PYLARIFY in prostate cancer therapeutic trials. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in March 2022, Lantheus Holdings Inc., a US-based diagnostic and imaging products company, partnered with Novartis AG, a Switzerland-based pharmaceutical company. With this partnership, they aim to use Lantheus' prostate-specific membrane antigen (PSMA) imaging agent, PYLARIFY (piflufolastat F18), in clinical trials for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to select patients with prostate cancer for enhanced diagnosis.

Prostate Cancer Diagnostics Market Merger And Acquisition: MDxhealth Sa Strengthens Prostate Diagnostics Portfolio Through Strategic Acquisition Of Exact Sciences Corporation

In August 2022, MDxHealth SA, a US-based commercial-stage precision diagnostics company, acquired Exact Sciences Corporation for an undisclosed amount. With this acquisition, MDxHealth enhanced its leadership in the precision diagnostics urology market and expanded its prostate diagnostics business with the Oncotype DX GPS (Genomic Prostate Score) test within the urology community. Exact Sciences Corporation is a US-based cancer screening and diagnostic tests company focused on cancer products, including prostate pipelines software to support patients before and throughout their cancer diagnosis and treatment.

Regional Outlook For The Global Prostate Cancer Diagnostics Market

North America was the largest region in the prostate cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prostate cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prostate Cancer Diagnostics Market?

The prostate cancer diagnostics market consists of revenues earned by entities by providing transrectal ultrasound, magnetic resonance imaging (MRI), and computerized tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. The prostate cancer diagnostics market also includes sales of products such as tumor biopsies, and test kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Prostate Cancer Diagnostics Industry?

The prostate cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides prostate cancer diagnostics market statistics, including prostate cancer diagnostics industry global market size, regional shares, competitors with a prostate cancer diagnostics market share, detailed prostate cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the prostate cancer diagnostics industry. This prostate cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Prostate Cancer Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$5.03 billion
Revenue Forecast In 2034	$8.17 billion
Growth Rate	CAGR of 12.9% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Products: Instruments, Reagents And Consumables, Accessories 2) By Test Type: Preliminary Tests, Confirmatory Tests 3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma 4) By Peer Groups: Adult, Pediatric, Geriatrics 5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users Subsegments: 1) By Instruments: Biopsy Instruments, Imaging Devices, Digital Rectal Examination Tools 2) By Reagents And Consumables: Diagnostic Assay Kits, Staining Reagents, Sample Collection Materials 3) By Accessories: Biopsy Guides, Specimen Handling Accessories, Calibration And Maintenance Tools
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc, Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc, NeoGenomics Laboratories Inc., Guardant Health Inc, GRAIL Inc, Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd, Exosome Diagnostics Inc., Dana-Farber Cancer Institute, Cellanyx Diagnostics Inc., A3P Biomedical AB
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Prostate Cancer Diagnostics Market Characteristics

3. Prostate Cancer Diagnostics Market Trends And Strategies

4. Prostate Cancer Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Prostate Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Prostate Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Prostate Cancer Diagnostics Market Growth Rate Analysis

5.4. Global Prostate Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Prostate Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Prostate Cancer Diagnostics Total Addressable Market (TAM)

6. Prostate Cancer Diagnostics Market Segmentation

6.1. Global Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Instruments

Reagents And Consumables

Accessories

6.2. Global Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preliminary Tests

Confirmatory Tests

6.3. Global Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Squamous Cell Cancer

Small Cell Carcinoma

Transitional Cell Cancer

Prostatic Adenocarcinoma

Ductal Adenocarcinoma

Small Cell Prostate Cancer

Acinar Adenocarcinoma

6.4. Global Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Pediatric

Geriatrics

6.5. Global Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Independent Diagnostic Laboratories

Cancer Research Institutes

Other End-Users

6.6. Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Instruments, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biopsy Instruments

Imaging Devices

Digital Rectal Examination Tools

6.7. Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Assay Kits

Staining Reagents

Sample Collection Materials

6.8. Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Accessories, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biopsy Guides

Specimen Handling Accessories

Calibration And Maintenance Tools

7. Prostate Cancer Diagnostics Market Regional And Country Analysis

7.1. Global Prostate Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Prostate Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prostate Cancer Diagnostics Market

8.1. Asia-Pacific Prostate Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prostate Cancer Diagnostics Market

9.1. China Prostate Cancer Diagnostics Market Overview

9.2. China Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prostate Cancer Diagnostics Market

10.1. India Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prostate Cancer Diagnostics Market

11.1. Japan Prostate Cancer Diagnostics Market Overview

11.2. Japan Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prostate Cancer Diagnostics Market

12.1. Australia Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prostate Cancer Diagnostics Market

13.1. Indonesia Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prostate Cancer Diagnostics Market

14.1. South Korea Prostate Cancer Diagnostics Market Overview

14.2. South Korea Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prostate Cancer Diagnostics Market

15.1. Western Europe Prostate Cancer Diagnostics Market Overview

15.2. Western Europe Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prostate Cancer Diagnostics Market

16.1. UK Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prostate Cancer Diagnostics Market

17.1. Germany Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prostate Cancer Diagnostics Market

18.1. France Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prostate Cancer Diagnostics Market

19.1. Italy Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prostate Cancer Diagnostics Market

20.1. Spain Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prostate Cancer Diagnostics Market

21.1. Eastern Europe Prostate Cancer Diagnostics Market Overview

21.2. Eastern Europe Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prostate Cancer Diagnostics Market

22.1. Russia Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prostate Cancer Diagnostics Market

23.1. North America Prostate Cancer Diagnostics Market Overview

23.2. North America Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prostate Cancer Diagnostics Market

24.1. USA Prostate Cancer Diagnostics Market Overview

24.2. USA Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prostate Cancer Diagnostics Market

25.1. Canada Prostate Cancer Diagnostics Market Overview

25.2. Canada Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prostate Cancer Diagnostics Market

26.1. South America Prostate Cancer Diagnostics Market Overview

26.2. South America Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prostate Cancer Diagnostics Market

27.1. Brazil Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prostate Cancer Diagnostics Market

28.1. Middle East Prostate Cancer Diagnostics Market Overview

28.2. Middle East Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prostate Cancer Diagnostics Market

29.1. Africa Prostate Cancer Diagnostics Market Overview

29.2. Africa Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prostate Cancer Diagnostics Market Competitive Landscape And Company Profiles

30.1. Prostate Cancer Diagnostics Market Competitive Landscape

30.2. Prostate Cancer Diagnostics Market Company Profiles

30.2.1. F. Hoffman-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Prostate Cancer Diagnostics Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company

31.2. Agilent Technologies Inc.

31.3. Hologic Inc

31.4. Biomerieux SA

31.5. Beckman Coulter Inc.

31.6. Qiagen N.V.

31.7. EXACT Sciences Corporation

31.8. Diasorin S.P.A.

31.9. OPKO Health Inc.

31.10. Myriad Genetics Inc.

31.11. Cepheid Inc

31.12. NeoGenomics Laboratories Inc.

31.13. Guardant Health Inc

31.14. GRAIL Inc

31.15. Fujirebio Diagnostics Inc.

32. Global Prostate Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prostate Cancer Diagnostics Market

34. Recent Developments In The Prostate Cancer Diagnostics Market

35. Prostate Cancer Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Prostate Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Prostate Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Prostate Cancer Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Instruments, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Accessories, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Prostate Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Prostate Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: F. Hoffman-La Roche AG Financial Performance

Table 80: Bayer AG Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Abbott Laboratories Inc. Financial Performance

Table 83: Siemens Healthineers AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Instruments, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Prostate Cancer Diagnostics Market, Sub-Segmentation Of Accessories, By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Prostate Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Prostate Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: F. Hoffman-La Roche AG Financial Performance

Figure 80: Bayer AG Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Abbott Laboratories Inc. Financial Performance

Figure 83: Siemens Healthineers AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Semiconductor Machinery Global Market Report 2025 – By Type (Front-End Equipment, Back-End Equipment, Fab Facility Equipment), By Product (Memory, Foundry, Logic, MPU, Discrete, Analog, MEMS, Other Products), By Supply Chain Participant (OSAT Companies, IDM Firms, Foundries), By Application (Integrated Circuit, Discrete Device, Optoelectronic Device, Sensors) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Machinery Global Market Report 2025 – By Type (Automatic, Semi-Automatic), By Capacity (Small, Medium, Large), By Application (Automotive, Precision Engineering, Transport, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Agriculture, Construction, And Mining Machinery Global Market Report 2025 – By Type (Construction Machinery, Agricultural Implement, Mining And Oil And Gas Field Machinery), By Operation (Autonomous, Semi-Autonomous, Manual), By Capacity (Small, Medium, Large) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Industrial Machinery Global Market Report 2025 – By Type (Woodworking And Paper Machinery, Printing Machinery And Equipment, Semiconductor Machinery, Food Product Machinery, Other Industrial Machinery), By Operation (Autonomous, Semi-Autonomous, Manual), By Capacity (Small, Medium, Large) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Metalworking Machinery Global Market Report 2025 – By Type (Special Die And Tool, Die Set, Jig, And Fixture, Machine Tool, Industrial Mold, Rolling Mill And Other Metalworking Machinery, Cutting Tool And Machine Tool Accessory), By Capacity (Small, Medium, Large), By Application (Automotive, Manufacturing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Fertilizing Machinery Global Market Report 2025 – By Product Type (Fertilizer Dryers, Fertilizer Screening Machines, Fertilizer Crushers, Fertilizer Granulators, Fertilizer Mixers), By Disc Type (Single Disc Fertilizer Spreaders, Double Disc Fertilizer Spreaders), By Application (Agriculture, Forestry, Greenbelt, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Farm Machinery And Equipment Global Market Report 2025 – By Type (Cultivator, Rotator, Chisel Plow, Harvester, Roller, Field Sprayer And Spreader, Irrigation System, Livestock equipment, Tractors, Other Types), By Capacity (Small, Medium, Large), By Operation (Manual, Semi-Autonomous, Fully-Autonomous), By Application (Spraying, Water Supply And Conservation, Cultivation, Harvesting, Seeding, Weeding, Livestock Farming, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Commercial And Service Industry Machinery Global Market Report 2025 – By Type (Commercial And Service Industry Machinery, Photographic And Photocopying Equipment, Optical Instrument And Lens), By Operation (Autonomous, Semi-Autonomous, Manual), By Capacity ( Small, Medium, Large) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Prostate Cancer Diagnostics market?

How will the Prostate Cancer Diagnostics market drivers and restraints affect the market dynamics? What forces will shape the Prostate Cancer Diagnostics industry going forward?

The Prostate Cancer Diagnostics market major growth driver - Global Surge In Prostate Cancer Cases Drives Expansion Of Prostate Cancer Diagnostics Market. For further insights on the Prostate Cancer Diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the Prostate Cancer Diagnostics market?

The Prostate Cancer Diagnostics market size has grown strongly in recent years. The prostate cancer diagnostics market size has grown rapidly in recent years. It will grow from $4.43 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to the increasing aging population, advancements in medical imaging, rising awareness and screening programs, public health initiatives, and improved biopsy techniques The prostate cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $8.17 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the integration of artificial intelligence (AI), growth of telemedicine in cancer screening, advancements in genomic profiling, patient-centric approaches, and multiparametric MRI for diagnosis. Major trends in the forecast period include liquid biopsy technologies, technological advances in biomarker detection, clinical research and development, digital pathology integration, emergence of multiplex biomarker assays. For further insights on the Prostate Cancer Diagnostics market, request a sample here

How is the Prostate Cancer Diagnostics market segmented?

The prostate cancer diagnostics market covered in this report is segmented –
1) By Products: Instruments, Reagents And Consumables, Accessories
2) By Test Type: Preliminary Tests, Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) By Peer Groups: Adult, Pediatric, Geriatrics
5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users Subsegments:
1) By Instruments: Biopsy Instruments, Imaging Devices, Digital Rectal Examination Tools
2) By Reagents And Consumables: Diagnostic Assay Kits, Staining Reagents, Sample Collection Materials
3) By Accessories: Biopsy Guides, Specimen Handling Accessories, Calibration And Maintenance Tools For further insights on the Prostate Cancer Diagnostics market, request a sample here

Which region has the largest share of the Prostate Cancer Diagnostics market? What are the other regions covered in the report?

North America was the largest region in the prostate cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Prostate Cancer Diagnostics market, request a sample here.

Who are the major players in the Prostate Cancer Diagnostics market?

What are the key trends in the Prostate Cancer Diagnostics market?

Major trends in the Prostate Cancer Diagnostics market include Innovative Technological Advancements Propel Prostate Cancer Diagnostics Market. For further insights on the Prostate Cancer Diagnostics market, request a sample here.

What are the major opportunities in the Prostate Cancer Diagnostics market? What are the strategies for the Prostate Cancer Diagnostics market?

For detailed insights on the major opportunities and strategies in the Prostate Cancer Diagnostics market, request a sample here.

How does the Prostate Cancer Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Prostate Cancer Diagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Prostate Cancer Diagnostics industry?

For detailed insights on the mergers and acquisitions in the Prostate Cancer Diagnostics industry, request a sample here.

What are the key dynamics influencing the Prostate Cancer Diagnostics market growth? SWOT analysis of the Prostate Cancer Diagnostics market.

For detailed insights on the key dynamics influencing the Prostate Cancer Diagnostics market growth and SWOT analysis of the Prostate Cancer Diagnostics industry, request a sample here.